Stock Updates

Amgen Inc. (NASDAQ: AMGN) – Is this large market cap stock undervalued?

Amgen Inc. (NASDAQ: AMGN), is firmly in the large market cap category with market cap of 123073.88. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Amgen Inc. is 164.75 (with a change from open of 1.16%), this in conjunction with a target price of 189.81. Volume today has so far reached 1006931, with an average volume of about 2767.49. The GAP for this stock, is -0.63%.

The P/E ratio is 16.77, bringing the forward P/E to a value of 13.11. The current EPS for Amgen Inc., is 9.77, with a EPS growth for this year coming to a value of 35.20%. Performance has been interesting with performance year to date coming to 2.92%.

Looking further into the growth statistics for Amgen Inc., EPS is looking like it will grow 10.07% in the next year. Looking even further it is projected to be 7.93%. Quarter over quarter is 14.90% for EPS growth and for sales growth quarter over quarter it is 5.90%. Looking at past EPS growth statistics we see that for the past five years it has been 13.60%. Sales growth for the past five years has in fact been 7.60%.

Looking at the ownership, we see that the insider ownership is at 0.20% and institutional ownership is 81.10%. Shares outstanding is 751, while shares float is at a value of 747.47. Float short for Amgen Inc. is 1.17% and the short ratio is 3.15.

In terms of debt, long term debt/equity is 0.93, while the total debt/equity comes to 1.1. The ability to meet these debts, means that the current ratio is 4, and the quick ratio is 3.7. The most recent gross margin is 81.40% and their operating margin is 40.70%. The profit margin is 33.10%.

Amgen Inc. has seen returns on assets of 10.10%, and on investment, 12.50%. Return on equity is 25.90%. Price/Earnings to growth ratio is 2.11. Price/Sales ratio is at a value of 5.48, with Price/book ratio coming to 4.08 and Price/cash is 3.51, and finally Price/Free cash Flow is 20.56.

The simple moving averages are -3.56% and 4.96% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -6.84% and the 52 week low is 19.98%.

Amgen Inc. has a dividend yield of 2.44%, with a current price of 164.75. The ability to pay this means the payout ratio is 36.30%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Amgen Inc. is based in USA.

Performance in the Biotechnology industry means that Amgen Inc. has seen performance for the past week of -2.01%, with performance for the month coming to -3.20%. Looking at the data for the quarter it is at a value of 1.29%, and for the half year the performance is 13.78%. Volatility for this week is 1.34% and for the month this is 1.46%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment